欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0273/001
药品名称Irinotecano Hikma
活性成分
    • irinotecan hydrochloride 3 H<2>O 20.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Hikma Farmacêutica (Portugal), S.A. Estrada do Rio da Mó, 8 - 8 A/B - Fervença Terrugem
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Italy (IT)
    • France (FR)
    • Germany (DE)
      Riboirino 20 mg /ml Konzentrat zur Herstellung einer Infusionslösung
    • Netherlands (NL)
      Irinotecan Hikma 20mg/ml , concentraat voor oplossing voor infusie
    • Austria (AT)
许可日期2009/07/22
最近更新日期2025/08/26
药物ATC编码
    • L01XX19 irinotecan
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase